NEW YORK, Oct. 14, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors in Rite Aid Corporation (“Rite Aid” or the
NEW YORK, Oct. 14, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Eve Holding, Inc. (“Eve” or the “Company”)
NEW YORK, Oct. 14, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors in Eve Holding, Inc. (“Eve” or the “Company”)
NEW YORK, Oct. 15, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Compass Minerals International, Inc. (“Compass” or the
It may seem like a drop in the bucket, but the $13 million Denmark has earmarked in aid for climate change-related “losses and damages” sets
NEW YORK, Oct. 14, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors in Cantaloupe, Inc. (“Cantaloupe” or the “Company”) (NASDAQ:
NEW YORK, Oct. 14, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Avidity Biosciences, Inc. (“Avidity” or the “Company”)
NEW YORK, Oct. 15, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Compass Minerals International, Inc. (“Compass” or the
NEW YORK, Oct. 14, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Cantaloupe, Inc. (“Cantaloupe” or the “Company”) CTLP.
NEW YORK, Oct. 14, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Avidity Biosciences, Inc. (“Avidity” or the “Company”)
NEW YORK, Oct. 14, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Flagstar Bancorp, Inc. (“Flagstar” or the “Company”)
NEW YORK, Oct. 14, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating allegations on behalf of investors of Y-mAbs Therapeutics, Inc. (“Y-mAbs” or the “Company”)
NEW YORK, Oct. 14, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors in Rite Aid Corporation (“Rite Aid” or the
NEW YORK, Oct. 14, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Eve Holding, Inc. (“Eve” or the “Company”)
NEW YORK, Oct. 14, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors in Eve Holding, Inc. (“Eve” or the “Company”)
NEW YORK, Oct. 15, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Compass Minerals International, Inc. (“Compass” or the
It may seem like a drop in the bucket, but the $13 million Denmark has earmarked in aid for climate change-related “losses and damages” sets
NEW YORK, Oct. 14, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors in Cantaloupe, Inc. (“Cantaloupe” or the “Company”) (NASDAQ:
NEW YORK, Oct. 14, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Avidity Biosciences, Inc. (“Avidity” or the “Company”)
NEW YORK, Oct. 15, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Compass Minerals International, Inc. (“Compass” or the
NEW YORK, Oct. 14, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Cantaloupe, Inc. (“Cantaloupe” or the “Company”) CTLP.
NEW YORK, Oct. 14, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Avidity Biosciences, Inc. (“Avidity” or the “Company”)
NEW YORK, Oct. 14, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Flagstar Bancorp, Inc. (“Flagstar” or the “Company”)
NEW YORK, Oct. 14, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating allegations on behalf of investors of Y-mAbs Therapeutics, Inc. (“Y-mAbs” or the “Company”)
